Advanced Biomaterials and Biomedical Applications
A special issue of Materials (ISSN 1996-1944). This special issue belongs to the section "Biomaterials".
Deadline for manuscript submissions: 20 March 2026 | Viewed by 8
Special Issue Editor
Interests: biomedical optics; biomedical imaging; signal and image processing; the development of imaging instruments and imaging technology; machine-learning-based image analysis and classification; retinal disease detection and treatment
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The advancement of healthcare increasingly relies on the design and application of innovative biomaterials that interact efficiently with the human body. Understanding the structure, properties, and behavior of both biological tissues and engineered materials is essential for driving progress in medical technologies. This Special Issue invites contributions that explore the development, fabrication, and characterization of biomedical materials, including bioprinting, drug delivery platforms, and synthetic tissue constructs. We also welcome studies on the mechanical, chemical, and biological properties of biomaterials, the interface between synthetic materials and living tissues, and strategies to enhance biocompatibility and functionality. Collectively, the research studies in this Special Issue aim to deepen our understanding of the materials science underlying biomedical applications and to highlight innovations that can improve diagnostics, therapeutics, and regenerative medicine.
We look forward to receiving your contributions.
Dr. Damber Thapa
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Materials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomaterials
- tissue engineering
- drug delivery systems
- bioprinting
- synthetic tissues
- biocompatibility
- biomedical devices
- nanomaterials
- biomaterial–tissue interface
- regenerative medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
